Samrat Pharmachem Limited

Equities

SAMRATPH6

INE103E01016

Pharmaceuticals

Delayed Bombay S.E. 04:36:29 2024-07-05 EDT 5-day change 1st Jan Change
337.2 INR +0.36% Intraday chart for Samrat Pharmachem Limited -0.43% -3.14%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Samrat Pharmachem Limited Announces Director Resignations CI
Crisil Gives BB+ Rating to Samrat Pharmachem's Bank Loans; Outlook Stable MT
Samrat Pharmachem Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Samrat Pharmachem Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Samrat Pharmachem Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Samrat Pharmachem Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Samrat Pharmachem Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Samrat Pharmachem Limited Recommends Dividend for the Financial Year Ended March 31, 2023 CI
Samrat Pharmachem Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Samrat Pharmachem Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Samrat Pharmachem Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022 CI
Samrat Pharmachem Limited Recommends Dividend for the Financial Year Ended March 31, 2022 CI
Samrat Pharmachem Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Samrat Pharmachem Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Samrat Pharmachem Limited Reports Earnings Results for the First Quarter Ended June 30, 2021 CI
Samrat Pharmachem Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021 CI
Samrat Pharmachem Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020 CI
Samrat Pharmachem Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020 CI
Samrat Pharmachem Limited Reports Earnings Results for the First Quarter Ended June 30, 2020 CI
Samrat Pharmachem Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020 CI
Samrat Pharmachem Limited Announces Company Secretary and Compliance Officer Changes CI
Samrat Pharmachem Limited Reports Earnings Results for the Third Quarter Ended December 31, 2019 CI
Samrat Pharmachem Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019 CI
Samrat Pharmachem Limited Reports Earnings Results for the First Quarter Ended June 30, 2019 CI
Samrat Pharmachem Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2019 CI
Chart Samrat Pharmachem Limited
More charts
Samrat Pharmachem Limited is an India-based company, which is engaged in the manufacturing and selling of pharmaceutical chemicals. The Company is a supplier of iodine derivatives to the Indian and foreign market. The Company’s products include 3-5-Di Iodosalicylic Acid, Ammonium Iodide, Calcium Iodide, Clioquinol, Copper Iodide, Ethyl Iodide, Ethylenediamine Dihydroiodide, Hydroiodic Acid 57%, Iodic Acid, Iodine, Iodine Monochloride, Iodoquinol, Lithium Iodide, Methyl Iodide, N-Iodo Succcinimide, Periodic Acid, Potassium Iodate, Potassium Iodide, Potassium Metaper Iodate, Povidone Iodine, Selenium Dioxide, Sodium Iodate, Sodium Iodide, Sodium Metaper Iodate, Sodium Selenite, Tetra Butyl Ammonium Iodide, and Tri Methyl Sulphoxonium Iodide. It serves various industries, such as agrochemical, animal feed, chemicals, food, pharmaceutical, printing, and textile. The Company exports its products to various countries, including United States, Europe, Africa, Asia, and Middle East.
More about the company
  1. Stock Market
  2. Equities
  3. SAMRATPH6 Stock
  4. News Samrat Pharmachem Limited
  5. Crisil Gives BB+ Rating to Samrat Pharmachem's Bank Loans; Outlook Stable